Earnings Release: Here's Why Analysts Cut Their ARYZTA AG (VTX:ARYN) Price Target To CHF66.45

It's been a sad week for ARYZTA AG (VTX:ARYN), who've watched their investment drop 14% to CHF45.25 in the week since the company reported its interim result. Results look mixed - while revenue fell marginally short of analyst estimates at €1.1b, statutory earnings were in line with expectations, at €4.25 per share. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on ARYZTA after the latest results.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

Following last week's earnings report, ARYZTA's four analysts are forecasting 2026 revenues to be €2.24b, approximately in line with the last 12 months. Statutory earnings per share are expected to shrink 5.0% to €4.02 in the same period. In the lead-up to this report, the analysts had been modelling revenues of €2.26b and earnings per share (EPS) of €4.44 in 2026. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year.

View our latest analysis for ARYZTA

It might be a surprise to learn that the consensus price target fell 8.3% to CHF66.45, with the analysts clearly linking lower forecast earnings to the performance of the stock price. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on ARYZTA, with the most bullish analyst valuing it at CHF76.01 and the most bearish at CHF40.06 per share. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the ARYZTA's past performance and to peers in the same industry. It's pretty clear that there is an expectation that ARYZTA's revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 3.8% growth on an annualised basis. This is compared to a historical growth rate of 7.2% over the past five years. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 3.2% annually. So it's pretty clear that, while ARYZTA's revenue growth is expected to slow, it's expected to grow roughly in line with the industry.

The Bottom Line

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for ARYZTA. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of ARYZTA's future valuation.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for ARYZTA going out to 2028, and you can see them free on our platform here.

You should always think about risks though. Case in point, we've spotted 2 warning signs for ARYZTA you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.